Molecular understanding of Aβ peptide interaction with isoflurane, propofol, and thiopental: NMR spectroscopic study

Biochemistry

Volumn 46, Issue 3, 2007, Pages 762-771

  Mandal, Pravat K ^a   Williams, John P ^b   Mandal, Ratna ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; CELLS; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; TOXICITY;

ISOFLURANE; OLIGOMERIZATION; PROPOFOL; THIOPENTAL;

AMINO ACIDS;

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; ISOFLURANE; NITROGEN 15; PROPOFOL; THIOPENTAL; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); ANESTHETIC AGENT; DODECYL SULFATE SODIUM; PEPTIDE FRAGMENT; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CONCENTRATION RESPONSE; DRUG PROTEIN BINDING; MOLECULAR INTERACTION; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN POLYMERIZATION; CHEMISTRY; MICELLE; NUCLEAR MAGNETIC RESONANCE; PROTEIN QUATERNARY STRUCTURE;

AMYLOID BETA-PROTEIN; ANESTHETICS; ISOFLURANE; MICELLES; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDE FRAGMENTS; PROPOFOL; PROTEIN STRUCTURE, QUATERNARY; SODIUM DODECYL SULFATE; THIOPENTAL;

EID: 33846385087     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi062184l     Document Type: Article

References (42)

1. McKeon-O'Malley, C., and Tanzi, R. (2001) Etiology, Genetics, and Pathogenesis of Alzheimer's Disease, Functional Neurology of Aging, pp 333-348, Academic Press, New York.
2. Duda, J. E., Lee, V. M. Y., and Trojanowski, J. Q. (2000) Neuropathology of synuclein aggregates: New insights into mechanisms of neurodegenerative diseases, J. Neurosci. Res. 61, 121-127,
3. Jarrett, J. T., Berger, E. P., and Lansbury, P. T. (1993) The carboxy terminus of the beta-amyloid protein is critical for the seeding of amyloid formation-implications for the pathogenesis of Alzheimers-disease, Biochemistry 32, 4693-4697.
4. Hardy, J. (1997) The Alzheimer family of diseases: many etiologies, one pathogenesis? Proc. Natl. Acad. Sci. U.S.A. 94, 2095-2097.
5. Eckenhoff, R. G., Johansson, J. S., Wei, H. F., Carnini, A., Kang, B. B., Wei, W. L., Pidikiti, R., Keller, J. M., and Eckenhoff, M. F. (2004) Inhaled anesthetic enhancement of amyloid-beta oligomerization and cytotoxicity, Anesthesiology 101, 703-709.
6. Xie, Z. C., Dong, Y. L., Maeda, U., Culley, D. J., Crosby, G., and Tanzi, R. E. (2006) The common inhalation anesthetic isoflurane induces apoptosis and increases amyloid beta protein levels, Anesthesiology 104, 988-994.
7. Mandal, P. K., Pettegrew, J. W., McKeag, D. W., and Mandal, R. (2006) Alzheimer's disease: halothane induces abeta peptide to oligomeric form-solution NMR studies, Neurochem. Res. 31, 883-890.
8. Eger, E. I., II, Saidman, L. J., and Brandstater, B. (1965) Minimum alveolar anesthetic concentration: a standard of anesthetic potency, Anesthesiology 26, 756-763.
9. Stevens, W. D., Dolan, W. M., Gibbons, R. T., White, A., Eger, E. I., Miller, R. D., DeJong, R. H., and Elashoff, R. M. (1975) Minimum alveolar concentrations (MAC) of isoflurande with and without nitrous oxide in patients of various ages, Anesthesiology 42, 197-200.
10. Franks, N. P., and Lieb, W. R. (1993) Selective actions of volatile general-anesthetics at molecular and cellular-levels, Br. J. Anaesth, 71, 65-76.
11. Eckenhoff, R. G., and Johansson, J. S. (1999) On the relevance of "clinically relevant concentrations" of inhaled anesthetics in in vitro experiments, Anesthesiology 91, 856-860.
12. Eckenhoff, R. G., and Johansson, J. S. (1997) Molecular interactions between inhaled anesthetics and proteins, Pharmacol. Rev. 49, 343-367.
13. Lerman, J., Gregory, G. A., Willis, M. M., and Eger, E. I., II. (1984) Age and solubility of volatile anesthetics in blood, Anesthesiology 61, 139-143.
14. Eger, E. I., II. (1992) Desflurane animal and human pharmacology: aspects of kinetics, safety, and MAC, Anesth. Analg. (Baltimore) 75, S3-S7; discussion S8-S9.
15. Knopes, K. D. (2002) Geriatric Anesthesiology, pp 29-30, American Geriatrics Society.
16. Mazoit, J. X., and Samii, K. (1999) Binding of propofol to blood components: implications for pharmacokinetics and for pharmacodynamics, Br. J. Clin. Pharmacol 47, 35-42.
17. Coates, K. M., Mather, L. E., Johnson, R., and Flood, P. (2001) Thiopental is a competitive inhibitor at the human alpha 7 nicotinic acetylcholine receptor, Anesth. Analg. (Baltimore) 92, 930-933.
18. Mandal, P. K., and Majumdar, A. (2004) A comprehensive discussion of HSQC and HMQC pulse sequences, Concepts Magn. Reson., Part A 20, 1-23.
19. Mandal, P. K., and Pettegrew, J. W. (2004) Alzheimer's disease: Soluble oligomeric Aβ(1- 40) peptide in membrane mimic environment from solution NMR and circular dichroism studies, Neurochem. Res. 29, 2267-2272.
20. Jerschow, A., and Muller, N. (1998) Diffusion-separated nuclear magnetic resonance spectroscopy of polymer mixtures, Macromolecules 31, 6573-6578.
21. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., and Bax, A. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes, J. Biomol. NMR 6, 277-293.
22. Garrett, D. S., Powers, R., Gronenborn, A. M., and Clore, G. M. (1991) A common sense approach to peak picking two-, three-and four-dimensional spectra using automatic computer analysis of contour diagrams, J. Magn. Reson. 95, 214-220.
23. Goddard, T. D., and Kneller, D. G. (1994) SPARKY 3, University of California, San Francisco, CA.
24. Mandal, P. K., and Pettegrew, J. W. (2004) Alzheimer's disease: NMR studies of asialo (GM1) and trisialo (GT1b) ganglioside interactions with Aβ(1- 40) peptide in a membrane mimic environment, Neurochem. Res. 29, 447-453.
25. Teplow, D. B. (1998) Structural and kinetic features of amyloid beta-protein fibrillogenesis, Amyloid 5, 121-142.
26. Coles, M., Bicknell, W., Watson, A. A., Fairlie, D. P., and Craik, D. J. (1998) Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? Biochemistry 37, 11064-11077.
27. Johansson, J. S., Zou, H., and Tanner, J. W. (1999) Bound volatile general anesthetics alter both local protein dynamics and global protein stability, Anesthesiology 90, 235-245.
28. Pidikiti, R., Zhang, T., Mallela, K. M. G., Shamim, M., Reddy, K. S., and Johansson, J. S. (2005) Sevoflurane-induced structural changes in a four-alpha-helix bundle protein, Biochemistry 44, 12128-12135.
29. Pidikiti, R., Shamim, M., Mallela, K. M. G., Reddy, K. S., and Johansson, J. S. (2005) Expression and characterization of a four-alpha-helix bundle protein that binds the volatile general anesthetic halothane, Biomacromolecules 6, 1516-1523.
30. Pohorille, A., Cieplak, P., and Wilson, M. A. (1996) Interactions of anesthetics with the membrane-water interface, Chem. Phys. 204, 337-345.
31. Yokono, S., Ogli, K., Miura, S., and Ueda, I. (1989) 400 MHz two-dimensional nuclear Overhauser spectroscopy on anesthetic interaction with lipid bilayer, Biochim. Biophys. Acta 982, 300-302.
32. Balasubramanian, S. V., Campbell, R. B., and Straubinger, R. M. (2002) Propofol, a general anesthetic, promotes the formation of fluid phase domains in model membranes, Chem. Phys. Lipids 114, 35-44.
33. Carnini, A., Lear, J. D., and Eckenhoff, R. G. (2006) Inhaled anesthetics modulation of amyloid beta(1-40). Assembly and growth, Curr. Alzheimer Res., in press.
34. Bedford, P. D. (1955) Adverse cerebral effects of anasthesia in old people, Lancet 259-263.
35. Ritchie, K., Nargoet, C., and Herguetta, T. (1992) Family observation of heterogeneity in early stage senile dementia of the Alzheimer type, Revue de Geriatrie 17, 251-258.
36. Moller, J. T., Cluitmans, P., Rasmussen, L. S., Houx, P., Rasmussen, H., Canet, J., Rabbitt, P., Jolies, J., Larsen, K., Banning, C. D., Langeren, O., Johnson, T., Lauven, P. M., Kristensen, P. A., Biedler, A., van Beem, H., Fraidakis, O., Silverstein, J. H., Beneken, J. E., and Gravenstein, J. S. (1998) Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study, Lancet 351, 857-861.
37. Seines, O. A., and McKhann, G. M. (2002) Cognitive changes after coronary artery bypass surgery, Curr. Opin. Psychiatry 15, 285-290.
38. Newman, M. F., Kirchner, J. L., Phillips-Bute, B., Gaver, V., Grocott, H., Jones, R. H., Mark, D. B., Reves, J. G., Blumenthal, J. A., and Cardi, N. O. R. G. (2001) Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery, N. Engl. J. Med. 344, 395-402.
39. Bone, I., and Rosen, M. (2000) Alzheimer's disease and anaesthesia, Anaesthesia 55, 592-593.
40. Bohnen, N. I. L. J., Warner, M. A., Kokmen, E., Beard, C. M., and Kurland, L. T. (1994) Alzheimers-disease and cumulative exposure to anesthesia-a case-control study, J. Am. Geriatr. Soc. 42, 198-201.
41. Kokmen, E., Beard, C. M., Chandra, V., Offord, K. P., Schoenberg, B. S., and Ballard, D. J. (1991) Clinical risk factors for Alzheimer's disease: a population-based case-control study, Neurology 41, 1393-1397.
42. Bohnen, N., Warner, M. A., Kokmen, E., and Kurland, L. T. (1994) Early and midlife exposure to anesthesia and age of onset of Alzheimer's disease, Int. J. Neurosci. 77, 181-185.